ResearchMoz

Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

GlobalData
Published Date » 2012-09-30
No. Of Pages » 174

Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

GlobalDatas new report, Glucose Monitoring Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 provides key market data on the Glucose Monitoring market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within three market categories Blood Glucose Test Strips, Blood Glucose Meters and Lancets. The report also provides company shares and distribution shares data for the overall Glucose Monitoring market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the worlds most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or oldera population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. Its estimated that shortly after 2020, Indias population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

  • Market size data for Glucose Monitoring market categories Blood Glucose Test Strips, Blood Glucose Meters and Lancets. 
  • Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the three market categories. Data from 2004 to 2011, forecast forward for seven years to 2018. 
  • 2011 company shares and distribution shares data for the overall Glucose Monitoring market in each of the aforementioned countries.
  • Global corporate-level profiles of key companies operating within the Glucose Monitoring market in BRICS.
  • Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, ARKRAY, Inc., Nipro Corporation and Terumo Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the Glucose Monitoring competitive landscape in BRICS.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table of Contents

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11

2 Introduction 14
2.1 What is This Report About? 14

3 Glucose Monitoring in BRICS 15
3.1 Glucose Monitoring, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15
3.2 Glucose Monitoring, BRICS, Company share (2010-2011) 20

4 Glucose Monitoring In Brazil 22
4.1 Glucose Monitoring, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 22
4.2 Blood Glucose Test Strips In Brazil 28
4.2.1 Blood Glucose Test Strips, Brazil, Overall Revenue (2004-2018) 28
4.2.2 Blood Glucose Test Strips, Brazil, Overall Volume (2004-2018) 30
4.2.3 Blood Glucose Test Strips, Brazil, Average Price (2004-2018) 32
4.3 Blood Glucose Meters In Brazil 33
4.3.1 Blood Glucose Meters, Brazil, Overall Revenue (2004-2018) 33
4.3.2 Blood Glucose Meters, Brazil, Overall Volume (2004-2018) 37
4.3.3 Blood Glucose Meters, Brazil, Average Price (2004-2018) 39
4.4 Lancets In Brazil 40
4.4.1 Lancets, Brazil, Overall Revenue (2004-2018) 40
4.4.2 Lancets, Brazil, Overall Volume (2004-2018) 42
4.4.3 Lancets, Brazil, Average Price (2004-2018) 44
4.5 Glucose Monitoring, Brazil, Distribution Share (2010-2011) 45
4.6 Glucose Monitoring, Brazil, Company Share (2010-2011) 46

5 Glucose Monitoring In Russian Federation 48
5.1 Glucose Monitoring, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 48
5.2 Blood Glucose Test Strips In Russian Federation 54
5.2.1 Blood Glucose Test Strips, Russian Federation, Overall Revenue (2004-2018) 54
5.2.2 Blood Glucose Test Strips, Russian Federation, Overall Volume (2004-2018) 56
5.2.3 Blood Glucose Test Strips, Russian Federation, Average Price (2004-2018) 58
5.3 Blood Glucose Meters In Russian Federation 59
5.3.1 Blood Glucose Meters, Russian Federation, Overall Revenue (2004-2018) 59
5.3.2 Blood Glucose Meters, Russian Federation, Overall Volume (2004-2018) 63
5.3.3 Blood Glucose Meters, Russian Federation, Average Price (2004-2018) 67
5.4 Lancets In Russian Federation 68
5.4.1 Lancets, Russian Federation, Overall Revenue (2004-2018) 68
5.4.2 Lancets, Russian Federation, Overall Volume (2004-2018) 70
5.4.3 Lancets, Russian Federation, Average Price (2004-2018) 72
5.5 Glucose Monitoring, Russian Federation, Distribution Share (2010-2011) 73
5.6 Glucose Monitoring, Russian Federation, Company Share (2010-2011) 74

6 Glucose Monitoring In India 76
6.1 Glucose Monitoring, India, Overall Revenue ($m), USD Constant, 2004-2018 76
6.2 Blood Glucose Test Strips In India 81
6.2.1 Blood Glucose Test Strips, India, Overall Revenue (2004-2018) 81
6.2.2 Blood Glucose Test Strips, India, Overall Volume (2004-2018) 83
6.2.3 Blood Glucose Test Strips, India, Average Price (2004-2018) 85
6.3 Blood Glucose Meters In India 86
6.3.1 Blood Glucose Meters, India, Overall Revenue (2004-2018) 86
6.3.2 Blood Glucose Meters, India, Overall Volume (2004-2018) 90
6.3.3 Blood Glucose Meters, India, Average Price (2004-2018) 92
6.4 Lancets In India 93
6.4.1 Lancets, India, Overall Revenue (2004-2018) 93
6.4.2 Lancets, India, Overall Volume (2004-2018) 95
6.4.3 Lancets, India, Average Price (2004-2018) 97
6.5 Glucose Monitoring, India, Distribution Share (2010-2011) 98
6.6 Glucose Monitoring, India, Company Share (2010-2011) 99

7 Glucose Monitoring In China 101
7.1 Glucose Monitoring, China, Overall Revenue ($m), USD Constant, 2004-2018 101
7.2 Blood Glucose Test Strips In China 107
7.2.1 Blood Glucose Test Strips, China, Overall Revenue (2004-2018) 107
7.2.2 Blood Glucose Test Strips, China, Overall Volume (2004-2018) 109
7.2.3 Blood Glucose Test Strips, China, Average Price (2004-2018) 111
7.3 Blood Glucose Meters In China 112
7.3.1 Blood Glucose Meters, China, Overall Revenue (2004-2018) 112
7.3.2 Blood Glucose Meters, China, Overall Volume (2004-2018) 116
7.3.3 Blood Glucose Meters, China, Average Price (2004-2018) 118
7.4 Lancets In China 119
7.4.1 Lancets, China, Overall Revenue (2004-2018) 119
7.4.2 Lancets, China, Overall Volume (2004-2018) 121
7.4.3 Lancets, China, Average Price (2004-2018) 123
7.5 Glucose Monitoring, China, Distribution Share (2010-2011) 124
7.6 Glucose Monitoring, China, Company Share (2010-2011) 125

8 Glucose Monitoring In South Africa 127
8.1 Glucose Monitoring, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 127
8.2 Blood Glucose Test Strips In South Africa 133
8.2.1 Blood Glucose Test Strips, South Africa, Overall Revenue (2004-2018) 133
8.2.2 Blood Glucose Test Strips, South Africa, Overall Volume (2004-2018) 135
8.2.3 Blood Glucose Test Strips, South Africa, Average Price (2004-2018) 137
8.3 Blood Glucose Meters In South Africa 138
8.3.1 Blood Glucose Meters, South Africa, Overall Revenue (2004-2018) 138
8.3.2 Blood Glucose Meters, South Africa, Overall Volume (2004-2018) 142
8.3.3 Blood Glucose Meters, South Africa, Average Price (2004-2018) 144
8.4 Lancets In South Africa 145
8.4.1 Lancets, South Africa, Overall Revenue (2004-2018) 145
8.4.2 Lancets, South Africa, Overall Volume (2004-2018) 148
8.4.3 Lancets, South Africa, Average Price (2004-2018) 150
8.5 Glucose Monitoring, South Africa, Distribution Share (2010-2011) 151
8.6 Glucose Monitoring, South Africa, Company Share (2010-2011) 152

9 Overview of Key Companies in BRICS Glucose Monitoring Market 154
9.1 F. Hoffmann-La Roche Ltd. 154
9.1.1 Company Overview 154
9.1.2 Share in the BRICS Glucose Monitoring Market 155
9.2 LifeScan, Inc. 156
9.2.1 Company Overview 156
9.2.2 Share in the BRICS Glucose Monitoring Market 157
9.3 Bayer HealthCare AG 158
9.3.1 Company Overview 158
9.3.2 Share in the BRICS Glucose Monitoring Market 159
9.4 Abbott Laboratories 160
9.4.1 Company Overview 160
9.4.2 Share in the BRICS Glucose Monitoring Market 161
9.5 ARKRAY, Inc. 162
9.5.1 Company Overview 162
9.5.2 Share in the BRICS Glucose Monitoring Market 163
9.6 Nipro Corporation 164
9.6.1 Company Overview 164
9.6.2 Share in the BRICS Glucose Monitoring Market 165
9.7 Terumo Corporation 166
9.7.1 Company Overview 166
9.7.2 Share in the BRICS Glucose Monitoring Market 167

10 Appendix 168
10.1 Definitions of Markets Covered in the Report 169
10.1.1 Glucose Monitoring 169
10.1.2 Insulin Delivery 169
10.1.3 Insulin Syringes 169
10.1.4 Traditional Insulin Pump Accessories 170
10.2 Research Methodology 171
10.3 Secondary Research 171
10.4 Primary Research 172
10.5 Models 172
10.6 Forecasts 173
10.7 Expert Panels 173
10.8 GlobalData Consulting 173
10.9 Currency Conversion 174
10.10 Contact Us 174
10.11 Disclaimer 174

List of Tables


Table 1: Glucose Monitoring, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15
Table 2: Glucose Monitoring, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 17
Table 3: Glucose Monitoring, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 19
Table 4: Glucose Monitoring, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011 21
Table 5: Glucose Monitoring, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 23
Table 6: Glucose Monitoring, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 25
Table 7: Glucose Monitoring, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 27
Table 8: Blood Glucose Test Strips, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 28
Table 9: Blood Glucose Test Strips, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 29
Table 10: Blood Glucose Test Strips, Brazil, Volume (Units), Historic, 2004-2011 30
Table 11: Blood Glucose Test Strips, Brazil, Volume (Units), USD Constant, Forecast, 2011-2018 31
Table 12: Blood Glucose Test Strips, Brazil, Average Price ($), Historic, 2004-2011 32
Table 13: Blood Glucose Test Strips, Brazil, Average Price ($), Forecast, 2011-2018 32
Table 14: Blood Glucose Meters, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 34
Table 15: Blood Glucose Meters, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 36
Table 16: Blood Glucose Meters, Brazil, Volume (Units) by Segment, Historic, 2004-2011 37
Table 17: Blood Glucose Meters, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 38
Table 18: Blood Glucose Meters, Brazil, Average Price ($), Historic, 2004-2011 39
Table 19: Blood Glucose Meters, Brazil, Average Price ($), Forecast, 2011-2018 39
Table 20: Lancets, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 40
Table 21: Lancets, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 41
Table 22: Lancets, Brazil, Volume (Units), Historic, 2004-2011 42
Table 23: Lancets, Brazil, Volume (Units), USD Constant, Forecast, 2011-2018 43
Table 24: Lancets, Brazil, Average Price ($), Historic, 2004-2011 44
Table 25: Lancets, Brazil, Average Price ($), Forecast, 2011-2018 44
Table 26: Glucose Monitoring, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011 45
Table 27: Glucose Monitoring, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011 47
Table 28: Glucose Monitoring, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 49
Table 29: Glucose Monitoring, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 51
Table 30: Glucose Monitoring, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 53
Table 31: Blood Glucose Test Strips, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 54
Table 32: Blood Glucose Test Strips, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 55
Table 33: Blood Glucose Test Strips, Russian Federation, Volume (Units), Historic, 2004-2011 56
Table 34: Blood Glucose Test Strips, Russian Federation, Volume (Units), USD Constant, Forecast, 2011-2018 57
Table 35: Blood Glucose Test Strips, Russian Federation, Average Price ($), Historic, 2004-2011 58
Table 36: Blood Glucose Test Strips, Russian Federation, Average Price ($), Forecast, 2011-2018 58
Table 37: Blood Glucose Meters, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 60
Table 38: Blood Glucose Meters, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 62
Table 39: Blood Glucose Meters, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011 64
Table 40: Blood Glucose Meters, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 66
Table 41: Blood Glucose Meters, Russian Federation, Average Price ($), Historic, 2004-2011 67
Table 42: Blood Glucose Meters, Russian Federation, Average Price ($), Forecast, 2011-2018 67
Table 43: Lancets, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 68
Table 44: Lancets, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 69
Table 45: Lancets, Russian Federation, Volume (Units), Historic, 2004-2011 70
Table 46: Lancets, Russian Federation, Volume (Units), USD Constant, Forecast, 2011-2018 71
Table 47: Lancets, Russian Federation, Average Price ($), Historic, 2004-2011 72
Table 48: Lancets, Russian Federation, Average Price ($), Forecast, 2011-2018 72
Table 49: Glucose Monitoring, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011 73
Table 50: Glucose Monitoring, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011 75
Table 51: Glucose Monitoring, India, Overall Revenue ($m), USD Constant, 2004-2018 76
Table 52: Glucose Monitoring, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 78
Table 53: Glucose Monitoring, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 80
Table 54: Blood Glucose Test Strips, India, Revenue ($m), USD Constant, Historic, 2004-2011 81
Table 55: Blood Glucose Test Strips, India, Revenue ($m), USD Constant, Forecast, 2011-2018 82
Table 56: Blood Glucose Test Strips, India, Volume (Units), Historic, 2004-2011 83
Table 57: Blood Glucose Test Strips, India, Volume (Units), USD Constant, Forecast, 2011-2018 84
Table 58: Blood Glucose Test Strips, India, Average Price ($), Historic, 2004-2011 85
Table 59: Blood Glucose Test Strips, India, Average Price ($), Forecast, 2011-2018 85
Table 60: Blood Glucose Meters, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 87
Table 61: Blood Glucose Meters, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 89
Table 62: Blood Glucose Meters, India, Volume (Units) by Segment, Historic, 2004-2011 90
Table 63: Blood Glucose Meters, India, Volume (Units) by Segment, Forecast, 2011-2018 91
Table 64: Blood Glucose Meters, India, Average Price ($), Historic, 2004-2011 92
Table 65: Blood Glucose Meters, India, Average Price ($), Forecast, 2011-2018 92
Table 66: Lancets, India, Revenue ($m), USD Constant, Historic, 2004-2011 93
Table 67: Lancets, India, Revenue ($m), USD Constant, Forecast, 2011-2018 94
Table 68: Lancets, India, Volume (Units), Historic, 2004-2011 95
Table 69: Lancets, India, Volume (Units), USD Constant, Forecast, 2011-2018 96
Table 70: Lancets, India, Average Price ($), Historic, 2004-2011 97
Table 71: Lancets, India, Average Price ($), Forecast, 2011-2018 97
Table 72: Glucose Monitoring, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 98
Table 73: Glucose Monitoring, India, Company Share by Revenue ($m), USD Constant, 2010-2011 100
Table 74: Glucose Monitoring, China, Overall Revenue ($m), USD Constant, 2004-2018 102
Table 75: Glucose Monitoring, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 104
Table 76: Glucose Monitoring, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 106
Table 77: Blood Glucose Test Strips, China, Revenue ($m), USD Constant, Historic, 2004-2011 107
Table 78: Blood Glucose Test Strips, China, Revenue ($m), USD Constant, Forecast, 2011-2018 108
Table 79: Blood Glucose Test Strips, China, Volume (Units), Historic, 2004-2011 109
Table 80: Blood Glucose Test Strips, China, Volume (Units), USD Constant, Forecast, 2011-2018 110
Table 81: Blood Glucose Test Strips, China, Average Price ($), Historic, 2004-2011 111
Table 82: Blood Glucose Test Strips, China, Average Price ($), Forecast, 2011-2018 111
Table 83: Blood Glucose Meters, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 113
Table 84: Blood Glucose Meters, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 115
Table 85: Blood Glucose Meters, China, Volume (Units) by Segment, Historic, 2004-2011 116
Table 86: Blood Glucose Meters, China, Volume (Units) by Segment, Forecast, 2011-2018 117
Table 87: Blood Glucose Meters, China, Average Price ($), Historic, 2004-2011 118
Table 88: Blood Glucose Meters, China, Average Price ($), Forecast, 2011-2018 118
Table 89: Lancets, China, Revenue ($m), USD Constant, Historic, 2004-2011 119
Table 90: Lancets, China, Revenue ($m), USD Constant, Forecast, 2011-2018 120
Table 91: Lancets, China, Volume (Units), Historic, 2004-2011 121
Table 92: Lancets, China, Volume (Units), USD Constant, Forecast, 2011-2018 122
Table 93: Lancets, China, Average Price ($), Historic, 2004-2011 123
Table 94: Lancets, China, Average Price ($), Forecast, 2011-2018 123
Table 95: Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 124
Table 96: Glucose Monitoring, China, Company Share by Revenue ($m), USD Constant, 2010-2011 126
Table 97: Glucose Monitoring, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 128
Table 98: Glucose Monitoring, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 130
Table 99: Glucose Monitoring, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 132
Table 100: Blood Glucose Test Strips, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 133
Table 101: Blood Glucose Test Strips, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 134
Table 102: Blood Glucose Test Strips, South Africa, Volume (Units), Historic, 2004-2011 135
Table 103: Blood Glucose Test Strips, South Africa, Volume (Units), USD Constant, Forecast, 2011-2018 136
Table 104: Blood Glucose Test Strips, South Africa, Average Price ($), Historic, 2004-2011 137
Table 105: Blood Glucose Test Strips, South Africa, Average Price ($), Forecast, 2011-2018 137
Table 106: Blood Glucose Meters, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 139
Table 107: Blood Glucose Meters, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 141
Table 108: Blood Glucose Meters, South Africa, Volume (Units) by Segment, Historic, 2004-2011 142
Table 109: Blood Glucose Meters, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 143
Table 110: Blood Glucose Meters, South Africa, Average Price ($), Historic, 2004-2011 144
Table 111: Blood Glucose Meters, South Africa, Average Price ($), Forecast, 2011-2018 144
Table 112: Lancets, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 146
Table 113: Lancets, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 147
Table 114: Lancets, South Africa, Volume (Units), Historic, 2004-2011 148
Table 115: Lancets, South Africa, Volume (Units), USD Constant, Forecast, 2011-2018 149
Table 116: Lancets, South Africa, Average Price ($), Historic, 2004-2011 150
Table 117: Lancets, South Africa, Average Price ($), Forecast, 2011-2018 150
Table 118: Glucose Monitoring, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011 151
Table 119: Glucose Monitoring, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011 153
Table 120: F. Hoffmann-La Roche Ltd., Revenue ($m), BRICS Glucose Monitoring Market, 2011 155
Table 121: LifeScan, Inc., Revenue ($m), BRICS Glucose Monitoring Market, 2011 157
Table 122: Bayer HealthCare AG, Revenue ($m), BRICS Glucose Monitoring Market, 2011 159
Table 123: Abbott Laboratories, Revenue ($m), BRICS Glucose Monitoring Market, 2011 161
Table 124: ARKRAY, Inc., Revenue ($m), BRICS Glucose Monitoring Market, 2011 163
Table 125: Nipro Corporation, Revenue ($m), BRICS Glucose Monitoring Market, 2011 165
Table 126: Terumo Corporation, Revenue ($m), BRICS Glucose Monitoring Market, 2011 167

List of Figures


Figure 1: Glucose Monitoring, BRICS, Overall Revenue ($m), USD Constant, 2004-2018 15
Figure 2: Glucose Monitoring, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011 16
Figure 3: Glucose Monitoring, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 18
Figure 4: Glucose Monitoring, BRICS, Company share (%), 2011 20
Figure 5: Glucose Monitoring, Brazil, Overall Revenue ($m), USD Constant, 2004-2018 22
Figure 6: Glucose Monitoring, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011 24
Figure 7: Glucose Monitoring, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 26
Figure 8: Blood Glucose Test Strips, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 28
Figure 9: Blood Glucose Test Strips, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 29
Figure 10: Blood Glucose Test Strips, Brazil, Volume (Units), Historic, 2004-2011 30
Figure 11: Blood Glucose Test Strips, Brazil, Volume (Units), USD Constant, Forecast, 2011-2018 31
Figure 12: Blood Glucose Meters, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 33
Figure 13: Blood Glucose Meters, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 35
Figure 14: Blood Glucose Meters, Brazil, Volume (Units) by Segment, Historic, 2004-2011 37
Figure 15: Blood Glucose Meters, Brazil, Volume (Units) by Segment, Forecast, 2011-2018 38
Figure 16: Lancets, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011 40
Figure 17: Lancets, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018 41
Figure 18: Lancets, Brazil, Volume (Units), Historic, 2004-2011 42
Figure 19: Lancets, Brazil, Volume (Units), USD Constant, Forecast, 2011-2018 43
Figure 20: Glucose Monitoring, Brazil, Company Share (%), 2011 46
Figure 21: Glucose Monitoring, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018 48
Figure 22: Glucose Monitoring, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011 50
Figure 23: Glucose Monitoring, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 52
Figure 24: Blood Glucose Test Strips, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 54
Figure 25: Blood Glucose Test Strips, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 55
Figure 26: Blood Glucose Test Strips, Russian Federation, Volume (Units), Historic, 2004-2011 56
Figure 27: Blood Glucose Test Strips, Russian Federation, Volume (Units), USD Constant, Forecast, 2011-2018 57
Figure 28: Blood Glucose Meters, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 59
Figure 29: Blood Glucose Meters, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 61
Figure 30: Blood Glucose Meters, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011 63
Figure 31: Blood Glucose Meters, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018 65
Figure 32: Lancets, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011 68
Figure 33: Lancets, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018 69
Figure 34: Lancets, Russian Federation, Volume (Units), Historic, 2004-2011 70
Figure 35: Lancets, Russian Federation, Volume (Units), USD Constant, Forecast, 2011-2018 71
Figure 36: Glucose Monitoring, Russian Federation, Company Share (%), 2011 74
Figure 37: Glucose Monitoring, India, Overall Revenue ($m), USD Constant, 2004-2018 76
Figure 38: Glucose Monitoring, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 77
Figure 39: Glucose Monitoring, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 79
Figure 40: Blood Glucose Test Strips, India, Revenue ($m), USD Constant, Historic, 2004-2011 81
Figure 41: Blood Glucose Test Strips, India, Revenue ($m), USD Constant, Forecast, 2011-2018 82
Figure 42: Blood Glucose Test Strips, India, Volume (Units), Historic, 2004-2011 83
Figure 43: Blood Glucose Test Strips, India, Volume (Units), USD Constant, Forecast, 2011-2018 84
Figure 44: Blood Glucose Meters, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 86
Figure 45: Blood Glucose Meters, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 88
Figure 46: Blood Glucose Meters, India, Volume (Units) by Segment, Historic, 2004-2011 90
Figure 47: Blood Glucose Meters, India, Volume (Units) by Segment, Forecast, 2011-2018 91
Figure 48: Lancets, India, Revenue ($m), USD Constant, Historic, 2004-2011 93
Figure 49: Lancets, India, Revenue ($m), USD Constant, Forecast, 2011-2018 94
Figure 50: Lancets, India, Volume (Units), Historic, 2004-2011 95
Figure 51: Lancets, India, Volume (Units), USD Constant, Forecast, 2011-2018 96
Figure 52: Glucose Monitoring, India, Company Share (%), 2011 99
Figure 53: Glucose Monitoring, China, Overall Revenue ($m), USD Constant, 2004-2018 101
Figure 54: Glucose Monitoring, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 103
Figure 55: Glucose Monitoring, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 105
Figure 56: Blood Glucose Test Strips, China, Revenue ($m), USD Constant, Historic, 2004-2011 107
Figure 57: Blood Glucose Test Strips, China, Revenue ($m), USD Constant, Forecast, 2011-2018 108
Figure 58: Blood Glucose Test Strips, China, Volume (Units), Historic, 2004-2011 109
Figure 59: Blood Glucose Test Strips, China, Volume (Units), USD Constant, Forecast, 2011-2018 110
Figure 60: Blood Glucose Meters, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 112
Figure 61: Blood Glucose Meters, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 114
Figure 62: Blood Glucose Meters, China, Volume (Units) by Segment, Historic, 2004-2011 116
Figure 63: Blood Glucose Meters, China, Volume (Units) by Segment, Forecast, 2011-2018 117
Figure 64: Lancets, China, Revenue ($m), USD Constant, Historic, 2004-2011 119
Figure 65: Lancets, China, Revenue ($m), USD Constant, Forecast, 2011-2018 120
Figure 66: Lancets, China, Volume (Units), Historic, 2004-2011 121
Figure 67: Lancets, China, Volume (Units), USD Constant, Forecast, 2011-2018 122
Figure 68: Glucose Monitoring, China, Company Share (%), 2011 125
Figure 69: Glucose Monitoring, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 127
Figure 70: Glucose Monitoring, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011 129
Figure 71: Glucose Monitoring, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 131
Figure 72: Blood Glucose Test Strips, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 133
Figure 73: Blood Glucose Test Strips, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 134
Figure 74: Blood Glucose Test Strips, South Africa, Volume (Units), Historic, 2004-2011 135
Figure 75: Blood Glucose Test Strips, South Africa, Volume (Units), USD Constant, Forecast, 2011-2018 136
Figure 76: Blood Glucose Meters, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011 138
Figure 77: Blood Glucose Meters, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018 140
Figure 78: Blood Glucose Meters, South Africa, Volume (Units) by Segment, Historic, 2004-2011 142
Figure 79: Blood Glucose Meters, South Africa, Volume (Units) by Segment, Forecast, 2011-2018 143
Figure 80: Lancets, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011 145
Figure 81: Lancets, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018 147
Figure 82: Lancets, South Africa, Volume (Units), Historic, 2004-2011 148
Figure 83: Lancets, South Africa, Volume (Units), USD Constant, Forecast, 2011-2018 149
Figure 84: Glucose Monitoring, South Africa, Company Share (%), 2011 152
Figure 85: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Glucose Monitoring Market, 2011 155
Figure 86: LifeScan, Inc., Company Share (%), BRICS Glucose Monitoring Market, 2011 157
Figure 87: Bayer HealthCare AG, Company Share (%), BRICS Glucose Monitoring Market, 2011 159
Figure 88: Abbott Laboratories, Company Share (%), BRICS Glucose Monitoring Market, 2011 161
Figure 89: ARKRAY, Inc., Company Share (%), BRICS Glucose Monitoring Market, 2011 163
Figure 90: Nipro Corporation, Company Share (%), BRICS Glucose Monitoring Market, 2011 165
Figure 91: Terumo Corporation, Company Share (%), BRICS Glucose Monitoring Market, 2011 167

Upcoming Reports:

Corn Starch Industry - Global Market Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The corn starch market is expected to witness significant growth due to developments in the field of biotechnology and new fermentation organisms that can produce new value-added chemicals.  This industry is growing rapidly and undergoing many technological changes. Research and development for bio-processing of corn starch to produce ethanol and other fermentation products is the current trend. Growing environmental pressure on the use of petroleum products and rising petroleum costs will result in an increase in the production of ethanol from corn starch, thereby...
Nitinol Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Nitinol a metal alloy is composed of with similar atomic percentages of nickel and titanium. There is an increase in the usage of nitinol devices due to the presence of two important properties namely superelasticity and shape memory. Thus, these properties of nitinol helps its it return to the original shape when heated at predetermined temperature. Since 1980’s the thermo-mechanical and biocompatibility characteristics of the material has expanded its usage across many medical and surgical specialties.  Due to its favorable characteristics usage of nitinol...
Control Valves Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Valves which are used to control pressure, temperature and level of liquid are called control valves. It is widely used in industries where the flow and level are required to be maintained. Control valves open or close responding to the process variable defined for its operation by means of electric and pneumatic actuators.   The major factors which are driving the control valves market includes: growing investment in the oil & gas sector. This automatically creates demand for control valves, as they find application right from the extraction of crude oil/gas...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...
Ontarios thanks Sustainable Development Technology Canada for Clean Tech Ecosystem Movements
Apr 8, 2014  
Sustainable Development Technology Canada has leveraged an extra $2.2 billion in funding from project partners that also includes global clean technology companies.  Sustainable Development Technology Canada (SDTC) is energizing and evolving the development and demonstration of a clean technology ecosystem. They are the vital contributors to the prominent concentration of clean...